Chain Reaction 2030
1. Financial overview
2. Shareholder structure
3. Technologies & business units
4. Other
Consolidated statement of comprehensive income
in Euro x 1,000
Continuing operations
Revenues
Other income
Total revenues and other income
Operating expenses
2020
Year ended
31 December
2019
2018
9,863
8,403
18,266
13,821
11,283
4,217
18,038
3,637
14,920
Raw materials and contract costs
(2,339)
(3,666)
Employee benefit expenses
(19,262)
(19,747)
(3,065)
(13,731)
Office and housing expenses
(1,990)
(1,800)
(2,208)
Patent, license, legal and advisory expenses
(4,204)
(3,185)
(1,897)
Laboratory expenses
(3,664)
(3,606)
Advertising and representation expenses
(679)
(1,438)
(1,737)
(1,311)
Expense due for onerous contract
492
Other operating expenses
Net operating expenses
(1,528)
(33,173)
(724)
(890)
(35,056)
(13,088)
(447)
(37,483)
EBITDA
(14,907)
(17,018)
Depreciation, amortisation and impairment
(7,597)
(5,948)
(22,563)
(1,799)
charge
EBIT
(22,504)
(22,966)
(24,362)
Finance costs net
(325)
Share in loss of joint ventures
Loss before income tax
(22,830)
(319)
(259)
(23,544)
(68)
(43,948)
(68,378)
Income tax expense
Loss for the period
(22,830)
(23,544)
(68,378)
Total comprehensive expense for the year
(22,830)
(23,544)
(68,378)
Avantium | Investor Presentation H2 2021
Loss attributable to:
Owners of the parent
(22,830)
(23,544)
(22,830)
(23,544)
(68,378)
(68,378)
Total comprehensive expense attributable to:
Owners of the parent
(22,830)
(23,544)
(68,378)
(22,830)
(23,544)
(68,378)
41View entire presentation